BOLALARDA OBSTRUKTİV BRONXITLARNI DAVOLASHDA POLIOKSIDONIYDAN FOYDALANISH
Abstrakt
Obstruktiv bronxit yosh bolalarning tez-tez kasalxonaga yotqizilishidan biri bo'lib, u bronxo-obstruktiv sindrom, nafas olish etishmovchiligining namoyon bo'lishi bilan tavsiflanadi. Obstruktiv bronxitning asosiy qo'zg'atuvchisi virusdir. Asosiy patogenetik bog'lanish bronxlarning yallig'lanishining shakllanishi bo'lganligi sababli, biz immunostimulyatsiya qiluvchi preparat - Polyoxidonium yordamida davolandik. Biz 2 guruhga bo'lingan 6 yoshdan 5 yoshgacha bo'lgan 64 nafar bemorni davoladik. Bemorlarga Respublika shoshilinch tibbiy yordam ilmiy markazi Samarqand filiali, pediatriya 1 va 2 bo‘limlarida statsionar sharoitda tibbiy yordam ko‘rsatildi. 2-guruhga Polyoxidonium buyurildi, u mushak ichiga 0,1 mg/kg dozada, har kuni 1 marta yuborildi. Tadqiqot natijalariga ko'ra, Polyoxidonium qabul qilgan bemorlarda siyanozni bartaraf etish (0,7 kunga; P<0,05), yo'talni kamaytirish (0,9 kunga; P<0,05), nafas olish etishmovchiligining yo'qolishi (0,7ga) sezilarli darajada tezlashgani qayd etildi. kun; P<0,05), nafas qisilishining yo'qolishi (1,4 kunga; P<0,001) nazorat guruhiga nisbatan. Shunday qilib, polioksidoniumdan foydalanish standart terapiya bilan solishtirganda kasalxonaga yotqizish muddatini o'rtacha 1,1 yotoq kuni (P<0,01) ga kamaytirishga olib keldi.
Kalit so'zlar:
Mualliflar haqida
Adabiyotlar ro'yxati
Maidannik V.G., Mitin Yu.V. Diagnosis, treatment and prevention of inflammatory respiratory diseases in children. K: IC Medprominfo 2006:288.
Ibragimova M. F. The use of the drug pectolvan c in the treatment of atypical pneumonia in children. Biology 2022:136.
Ibragimova M. F. diagnostic criteria for pneumonia of atypical etiology in children. British Medical Journal 2022;2.
Karaulov АВ, Gorolev АВ. The use of azoximer bromide in the treatment of infectious and inflammatory respiratory diseases in children: a meta-analysis of controlled clinical trials. Journal of Infectology 2019;11:31–41. https://doi.org/10.22625/2072-6732-2019-11-4-31-41.
Fedorovna IM. THE INFLUENCE OF RISK FACTORS ON THE DEVELOPMENT OF ATYPICAL PNEUMONIA IN YOUNG CHILDREN. Asian Journal of Pharmaceutical and Biological Research 2022;11.
Fedorovna IM, Kizi SZS, Shodiyorovna GD. IMPROVED DIAGNOSIS AND TREATMENT OF ATYPICAL PNEUMONIA IN CHILDREN. Thematics Journal of Applied Sciences 2023;7.
Janssen R, Bont L, Siezen CLE, Hodemaekers HM, Ermers MJ, Doornbos G, et al. Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes. J Infect Dis 2007;196:826–34. https://doi.org/10.1086/520886.
Irgashevna KN. IMMUNE STATUS AND CLINICAL AND DIAGNOSTIC FEATURES OF THE COURSE OF CHRONIC BRONCHITIS IN CHILDREN. International Journal of Scientific Pediatrics 2022:25–30.
P.Pruzhinets, N. Chirun, O. Sveikata. Safety profile of Polyoxidonium in daily practice: results of a post-registration safety study in Slovakia. Immunotherapy 2018:1–7.
Tatochenko V. K. Respiratory diseases: a practical guide. A practical guide Edited by V K Tatochenko M: Pediatrician 2012:480.
Qanday qilib iqtibos keltirish kerak
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
